Spinal Muscular Atrophy Type 2 Latest Advances

Characteristics of early-onset, rapidly progressive scoliosis in spinal muscular atrophy type I treated with disease-modifying therapy -a multicenter retrospective study conducted in Japan.

Journal: Journal of neuromuscular diseases

Published: January 07, 2026

Cognitive and neurodevelopmental disorders in spinal muscular atrophy type I at the time of disease-modifying therapies.

Journal: Developmental medicine and child neurology

Published: December 23, 2025

Body Weight and Range of Motion as Predictors of Trunk Asymmetry in Children With Spinal Muscular Atrophy: A Prospective Functional Assessment.

Journal: Medical science monitor : international medical journal of experimental and clinical research

Published: December 23, 2025

Effects of physical therapy on motor ability in patients with spinal muscular atrophy III: a study protocol for a randomised controlled trial.

Journal: BMJ open

Published: December 03, 2025

Comparative Clinical Outcomes of Nusinersen and Gene Therapy in Spinal Muscular Atrophy Type 1.

Journal: JAMA network open

Published: October 08, 2025

Reviewer Comment on Gauvreau et al. "Respiratory and Bulbar Support in Spinal Muscular Atrophy Type I Treated with Nusinersen".

Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques

Published: October 03, 2025

Results in our symptomatic and presymptomatic SMA patients treated with disease-modifying therapy

Journal: Ideggyogyaszati szemle

Published: October 01, 2025

PMP22-Related Neuropathies: A Systematic Review.

Journal: Genes

Published: September 29, 2025

A sensory and motor neuropathy caused by a genetic variant of NAMPT.

Journal: Science advances

Published: September 26, 2025

Isolated peripheral neuropathy in a young adult: the role of comprehensive genetic testing.

Journal: BMJ case reports

Published: September 19, 2025

Co-occurrence of ipsilateral partial Horner's syndrome in a patient with monomelic amyotrophy.

Journal: BMJ case reports

Published: September 05, 2025

Disease-modifying therapies for spinal muscular atrophy: Family experience, ethical considerations, and the role of social determinants of health.

Journal: Journal of neuromuscular diseases

Published: September 03, 2025